Studies in progress

Epilepsy study

Additional male volunteers, between the ages of 20 and 40, who do not have epilepsy are needed for an ongoing imaging study of epilepsy. Routine brain scans that take approximately two hours on each of two days are needed for comparison to epilepsy patients. The study pays $150. Call 712-7954.

At risk for glaucoma study

Persons 40-80 years of age who either have ocular hypertension--a higher than normal pressure within the eye--or are at risk for developing glaucoma as determined by their eye doctor, may be eligible to participate in the Emory component of a national eye study. Qualified participants include those who have never undergone glaucoma surgery and have at least two of the following risk factors: a family history of glaucoma, diabetes, high blood pressure, nearsightedness or are African American. Study medications will be provided free of charge. For information, call Donna Leef at 778-4134.

Adult trauma victim study

Emory researchers are offering help to adult trauma victims with post-traumatic stress disorder (PTSD) through a study in the Department of Psychiatry and Behavioral Sciences. PTSD is characterized by nightmares, fears, avoidance and sleep difficulties, and is common following traumas such as rape, accidents, war and assault. The study is using the non-addicting investigational medication Zoloft. For information, call 727-8968.

Oral contraceptive study

Women are being recruited for a study testing a new oral contraceptive beginning in the Reproductive Endocrinology Division of the School of Medicine's Department of Gynecology and Obstetrics. Volunteers should be over 18 years of age and may not have undergone menopause. Qualified participants may not have a history of side effects associated with taking birth control pills, such as migraine headaches or high blood pressure. Volunteers also should not have a history of severe depression, diabetes, blood clotting disorders or chronic kidney disease. All physical examinations, blood tests, PAP smears and medication associated with the study will be provided free-of-charge. For information, call 686-8127.